FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31.
Fibrogen Inc (FGEN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 7,936,000 | $18,649,600 | -19% | 0.24% |
| 2. | Citadel Investment Group Ken Griffin | 2,013,768 | $4,732,355 | -16% | 0% |
| 3. | 683 Capital Partners Ari Zweiman | 1,850,000 | $4,347,500 | +165% | 0.31% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 1,204,300 | $2,830,105 | -34% | 0% |
| 5. | Point72 Asset Management Steve Cohen | 1,080,264 | $2,538,620 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.17 | 22,123 | 82,123 | 2024-06-12 | Filing | ||
| $1.91 | 50,000 | 470,178 | 2024-03-07 | Filing | ||
| $11.53 | 3,100 | Officer | 48,816 | 2021-08-26 | Filing | |
| $35.28 | 19,800 | Officer, Director | 27,800 | 2020-06-11 | Filing | |
| $36.29 | 8,000 | Officer, Director | 8,000 | 2020-06-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.03 | 2,000 | Director | 28,866 | 2023-09-01 | Filing | |
| $1.91 | 2,000 | Director | 30,866 | 2023-08-04 | Filing | |
| $2.69 | 2,000 | Director | 32,866 | 2023-07-11 | Filing | |
| $2.80 | 1,880 | Officer, Director | 374,722 | 2023-07-07 | Filing | |
| $16.53 | 791 | Officer | 108,261 | 2023-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,471,928 | $12,826,470 | 0.01% | |
| 2. | 7,205,300 | $6,386,058 | 0% | |
| 3. | 7,044,149 | $6,243,229 | 0% | |
| 4. | 2,489,506 | $2,206,449 | 0.01% | |
| 5. | 2,226,857 | $1,973,663 | 0% |
News See All
FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.42. FibroGen, Inc.
FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the FibroGen's Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the FibroGen's Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to FibroGen's First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to FibroGen's Fourth Quarter and Full Year 2022 Financial Results Earnings Call. . I would now like to hand the call over to your host, Mike Tung.
5 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
In this piece, we will look at the ten stocks under $30 to buy today according to billionaire Steven Cohen.
Were Hedge Funds Right About FibroGen Inc (FGEN)?
In this article we will check out the progression of hedge fund sentiment towards FibroGen Inc (NASDAQ:FGEN) and determine whether it is a good investment right now.
Hedge Funds Have Never Been More Bullish On FibroGen Inc (FGEN)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
